Agilent Technologies, Inc.
Billionaire Paul Tudor Jones (PTJ) has been all over the news after telling an audience of University of Virginia students and others that it's difficult for mothers to be successful traders given that their connection to a child is a focus "killer." PTJ has been one of the most successful traders over the past few decades, with a net worth of some $3.3 billion. Let's check out more »
Is Life Technologies overvalued?
On April 15th 2013, Thermo fisher announced its acquisition of Life technologies (LIFE) for $13.6 billion plus the approximately $2.2 billion in net debt. This report analyses the growth of Life technologies and concludes whether LIFE is over- or undervalued.
About Life Technologies
Life technologies produces systems and reagents that enable and simplify biological research within academic, clinical, and commercial research applications.
Q1 more »
On April 15th 2013, Thermo fisher announced to acquire Life technologies (LIFE) for $13.6 billion plus the assumption of net debt of around $2.2 billion. This report analyses the growth of Life technologies and concludes if LIFE is overvalued or under valued
About Life Technologies
Life technologies is a company that produces systems and reagents that enable and simplify the biological research of genes proteins and cells more »
Agilent Technologies (NYSE: A) is one of the leading manufacturers of measurement and testing instruments, and has exposure to many sectors, making it a great diversification play. With nicely growing revenues, a great balance sheet, and a share price that is still about 10% below its 52-week high despite the incredible rally in the markets, is Agilent worth a look?
About Agilent Technologies
Agilent Technologies, which was spun off from more »
Within the past 12 months, industrial equipment manufacturer Roper Industries (NYSE: ROP) has made two important acquisitions that have the potential to reorder the company's focus and boost its bottom-line earnings.
In mid-2012, Roper inked a $1.4 million cash purchase deal with privately held Sunquest Information Systems, an important player in the laboratory software industry. More recently, the company agreed to purchase privately held Managed Health Care Associates more »
After a long takeover battle, Thermo Fisher Scientific (NYSE: TMO) has agreed on a takeover deal with merger partner, Life Technologies (NASDAQ: LIFE). The cash-and-debt deal would cost roughly $13.6 billion and result in Thermo's assumption of over $2 billion in Life's debt.
This deal is notable for several reasons. Among other things, Thermo beat out a consortium of private equity firms with an apparently superior bid more »
Agilent Technologies (NYSE: A) is a highly diversified company, although almost half (48%) of its sales are generated by the Electronic Measurements Group (EMG). The recent reduction in this segment's sales led to a sell-off, providing an interesting entry point for long-term investors. I think that shares are expected to perform well based on three key reasons.
Good position to benefit from an economic recovery
Agilent largely relies on more »
The big news in the medical service and device sector is the speculated buyout of Life Technologies (NASDAQ: LIFE). However, I believe investors could snatch up Agilent Technologies (NYSE: A) for a "good" price amid the hype surrounding Life.Agilent provides bio-analytic and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries, meaning it has a bit more of a diversified portfolio, serving not only the more »
Since the beginning of the year, shareholders of Life Technologies (NASDAQ: LIFE) must be quite happy as its share price advanced significantly, from $49 per share to nearly $67 per share, a four-month gain of 36.7%. Recently, the company received a bid of $65 per share from a buyout group, which includes Blackstone Group, Carlyle Group, KKR & Co, and Temasek Holdings. However, Thermo Fisher Scientific (NYSE: TMO) placed a more »
With the markets recovering since early 2013 there are certain companies who share you must closely watch or a wide to generate considerable amounts of profits on the New York Stock Exchange and NASDAQ. The stocks that you must carefully watch include the stocks of Agilent Technologies Inc (NYSE: A), B&G Foods Inc (NYSE: BGS), Qlik Technologies Inc (NASDAQ: QLIK), Ellie Mae Inc (NYSE: ELLI) and LogMeIn Inc (NASDAQ more »
Innovation coupled with high returns on investment is what our analysts smell for the near future. With a revenue of $1.84 billion in 2012, Waters Corporation (NYSE: WAT), an analytical instrument manufacturer, is driving scientific discovery and operational excellence for customers worldwide. The company, founded in 1958 is based in Milford, Massachusetts and operates in two segments: Waters Division & TA Division. Through its Waters Division, the company designs, manufactures more »
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company and its future. As 2013 begins, I would like to focus on a diversified science and technology giant: Danaher Corporation (NYSE: DHR).
- Solid Revenue Growth: In 2007, Danaher reported revenue of $11.03 billion; in 2012, the company announced more »
A shareholder-friendly company holds certain advantages over a typical stock, if in fact it returns capital to shareholders in terms of performance as well as in yield. In this market there are numerous examples of such stocks, and in this article I am looking at five that are raising their dividend and might fit into your portfolio.
Increase Over 2012
2 more »
Don't we all love stories about bands that started in garages like Blink 182 or The Hives or mega cap tech companies founded by two nerds in their parents' garage? (Think Apple, Google, Amazon, Hewlett-Packard). There's just something so All American about it. The most iconic of companies like Mattel, Harley-Davidson, and Disney share rags to riches beginnings in garages.
It's so fairy tale and mythic like more »
If you are seeking exposure to the electronic equipment industry, there are several factors you should look at. First, consider the segments and geographical exposure. If you are bullish on life sciences over tech, you might want to consider preferentially backing their suppliers (unless, you want to hedge, or limit, your risks). Second, look at how successful R&D has been in driving free cash flow or whether it is more »
Agilent Technologies (NYSE: A), a leading service provider of bio-analytical and electronic measurement solutions recently released its fourth quarter earnings. The company has shown an increase of 50 basis points (bps) in its gross margin from the year ago-quarter due to efficient cost management, but company's pessimism about its future earnings in its conference call is a source of worry. I beleive operating in a cyclical industry with its more »
Despite the common perception of insider trading, it remains a fact that out of the hundreds of thousands of insider transactions every year, just a tiny fraction are ruled to be unlawful. In case you haven't heard, the SEC may have just broken open the most significant case of illegal insider trading in history. As originally reported by Business Insider, Mathew Martoma, a former hedge fund manager employed by more »
I think that Agilent (NYSE: A) is a great barometer of a cyclical companies willingness to undergo capital expenditures. If companies are expanding CapEx then they will need to invest in test and measurement instrumentation. With this in mind Agilent’s recent results and commentary were not exactly encouraging. I want to break them down and see the areas of relative strengths/weaknesses with reference to Agilent’s and other more »
Earnings season starts to wind down this week, but there are still some interesting companies reporting. I think by now most investors will have formulated their view on the general trend of earnings and the economy. This week is probably about confirming- already drawn- conclusions.
For the record, I think it has been a bit of a watershed earnings season. I’ve been a bit negative on emerging markets (EM more »
With demand in technology soaring, investors should start eyeing suppliers. Backing any one end market, like tablets, is risky given how fickle consumers can be. However, diversifying investments can be tricky considering how many markets there are to choose from. Suppliers, however, have already exposed themselves to end markets and, in a sense, done much of the research for you. I recommend considering some of the folloing investments as a more »
- Page 1 of 2